Statement on the use of cannabidiol for mental disorders
Cannabidiol is a natural compound found in the cannabis plant. It has been linked to several pharmacological effects in recent years and has been recognised as a prescription medication in, for example, Germany since 2016.
However, due to limited data on dosing and effectiveness, as well as the inconsistent quality of cannabidiol available on the market, we currently cannot recommend its use for mental disorders.
We do NOT endorse the use of cannabidiol for self-initiated therapy or assisting patients or doctors in this area. We strongly oppose third-party advice on this matter, as most advertised cannabidiol products do not meet the high standards required for prescription medicines or provide a CBD dose close to what is purported to be needed.
It is important to note that many patients who have contacted us have not had access to the full range of approved treatment options. Our group is currently conducting clinical trials on the use of cannabidiol in early psychosis/schizophrenia, which can be found, e.a, at CBD-ESPRIT.de.
However, due to limited data on dosing and effectiveness, as well as the inconsistent quality of cannabidiol available on the market, we currently cannot recommend its use for mental disorders.
We do NOT endorse the use of cannabidiol for self-initiated therapy or assisting patients or doctors in this area. We strongly oppose third-party advice on this matter, as most advertised cannabidiol products do not meet the high standards required for prescription medicines or provide a CBD dose close to what is purported to be needed.
It is important to note that many patients who have contacted us have not had access to the full range of approved treatment options. Our group is currently conducting clinical trials on the use of cannabidiol in early psychosis/schizophrenia, which can be found, e.a, at CBD-ESPRIT.de.